Latest News
Cloud ETFs Rebound as Tech Recovers, Amazon's AI Spending Weighs
Cloud computing ETFs gained 2-4% Friday amid a tech rebound, while Amazon fell 5.6% on concerns over its $200B AI infrastructure plan. Key economic data this week may shift rate expectations.
Hims Halts Compounded GLP-1 Pill as FDA Cracks Down, Molina Plunges on Profit Warning
Hims & Hers discontinues its $49 compounded semaglutide offering following FDA enforcement signals, sending shares down 16%. Molina Healthcare forecasts 2026 profit far below expectations, triggering a 28% stock drop.
Communication Services Sector Lags as AI Spending Concerns Weigh on Big Tech
The Communication Services ETF (XLC) fell 0.4% Friday, diverging from a broad market rally, as Alphabet and Meta declined. Investors scrutinized massive AI capital expenditure plans.
Quantum Computing Stocks Surge as Tech Sector Rebounds
Shares of quantum computing companies soared Friday, with IonQ, Rigetti, D-Wave, and Quantum Computing Inc gaining 15-21% amid a broad tech rally. Heavy trading volume accompanied the moves.
Ucore Rare Metals Surges 15% as Critical Minerals Policy Fuels Sector Rally
Ucore Rare Metals shares jumped nearly 15% on Friday, leading a broader rally in rare earth stocks amid renewed focus on North American critical minerals policy and supply chain security.
AI Investment Splits Tech as Dow Tops 50,000
The Dow Jones Industrial Average closed above 50,000 for the first time, driven by chipmakers like Nvidia, while Amazon fell sharply on news of a massive $200 billion capital expenditure plan for 2026. Investors are scrutinizing soaring AI infrastructure costs.
EV Stocks Rally on UBS Lucid Bet; Stellantis Takes $26.5B Charge
Lucid surged 14% after UBS disclosed a major stake, leading a rebound in EV shares. Stellantis plunged up to 30% in Europe after booking a massive $26.5 billion charge related to its electric vehicle strategy.
Merck Nears 52-Week Peak Amid Insider Sale, Investors Eye Pipeline Updates
Merck shares climbed 1.8% to $121.93, extending gains for a seventh session and approaching a 52-week high. An executive sold 37,685 shares as investors await the impact of 2026 guidance and pipeline developments.
AstraZeneca Shares Hold Ground Ahead of Key Earnings, TrumpRx Pricing Initiative Looms
AstraZeneca shares edged higher ahead of its full-year results, with 2026 guidance and U.S. drug pricing pressures in focus. The stock closed up 0.9% in London and 3.2% in New York.
Toyota Names Finance Chief as New CEO, Lifts Profit Outlook Ahead of Key Week
Toyota Motor appointed CFO Kenta Kon as its next chief executive and raised its full-year operating profit forecast to 3.8 trillion yen, sending shares near a one-year high. Investors are monitoring currency moves, U.S. tariffs, and a tender offer deadline this week.
LVMH Shares Extend Decline as Investors Await Key Economic Data
LVMH shares fell 0.37% to €536.20, extending a post-earnings slump. Traders are focused on upcoming U.S. jobs and inflation reports for clues on luxury demand.